以岭药业荣获“美丽中国”杰出贡献奖

Group 1 - The core viewpoint of the article highlights that Yiling Pharmaceutical (002603) has been awarded the "Outstanding Contribution Award for Beautiful China" in the 2025 ESG Model Enterprise List for its exceptional practices in ecological environment protection and sustainable development [1][2] - The evaluation gathered over 40 enterprises from various sectors including high-end manufacturing, green energy, digital technology, finance, and consumption, aiming to depict a corporate image that internalizes ESG concepts as a core driving force for high-quality development in the context of Chinese modernization [1][2] - Yiling Pharmaceutical has integrated environmental protection into its corporate development strategy, establishing an ESG practice system characterized by the traditional Chinese medicine industry, which includes ecological planting of medicinal materials and innovative green production processes [1][2] Group 2 - The recognition of Yiling Pharmaceutical signifies the high acknowledgment of ESG practices within the traditional Chinese medicine sector, providing a model for sustainable development in the industry [2] - The ongoing ESG model enterprise evaluation initiated by Observer Network since 2024 aims to promote the transition of ESG from a concept to actionable practices, focusing not only on environmental performance but also on social responsibility and corporate governance [2] - Under the guidance of high-quality development principles, Chinese enterprises like Yiling Pharmaceutical demonstrate that economic benefits and environmental benefits can mutually promote each other, contributing Chinese wisdom and solutions to global sustainable development [2]